In The
Media

Cerecin, developing an oral Alzheimer’s drug, appoints Korean CFO as it takes on the K-bio market

Cerecin, developing an oral Alzheimer’s drug, appoints Korean CFO as it takes on the K-bio market

Link to Article Here

en_USEnglish
ko_KRKorean en_USEnglish